Furthermore, Kaplan-Meier analysis showed that SHMT2 expression was significantly associated with poor overall survival in CRC patients (HR 2.72, 95% CI 1.24–5.97, P=0.0125, Figure 1(d)). The gene discussed is SHMT2; the disease is colorectal carcinoma.